FDA Inspection 1250587 — Versiti Blood Health, Inc
The FDA completed an inspection of Versiti Blood Health, Inc on September 30, 2024 in Indianapolis, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 30, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Indianapolis, IN (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 12371 | 21 CFR 1271.200(a) | Cleaned, sanitized per established schedules |
| 12431 | 21 CFR 1271.265(e) | Procedures and release criteria |
| 12437 | 21 CFR 1271.270(a) | Records incomplete |
| 154 | 21 CFR 606.160(a)(1) | Concurrent documentation |
| 160 | 21 CFR 606.160(a)(1) | Person performing, test results, interpretation |
| 76 | 21 CFR 606.100(b) | Establish, maintain and follow manufacturing SOPs |